Caladrius Biosciences, Inc. (LSTA) Tops Q3 EPS by 16c

Caladrius Biosciences, Inc. (NASDAQ: LSTA) reported Q3 EPS of ($0.59), $0.16 better than the analyst estimate of ($0.75).

For earnings history and earnings-related data on Caladrius Biosciences, Inc. (LSTA) click here.

You May Also Be Interested In

• Walmart (WMT) Tops Q2 EPS by 7c, Beats on Revenue; Offers FY27 EPS Guidance
• Daqo New Energy (DQ) Misses Q2 EPS by 67c
• Advance Auto Parts (AAP) Tops Q2 EPS by 22c; lifrs profit guidance